View Report Details  Cardiac Rhythm Management Market---------------------------------------------------------            ...
View Report DetailsExecutive SummaryCardiac rhythm management (CRM) is a well established segment of the cardiology device...
Cardiac rhythm management (CRM) is a field of treatment in cardiology, which primarily manages cardiac                    ...
CRM market is bifurcated into two segments viz. Implantable Cardiac Defibrillators (ICD) and Pacemaker                    ...
The Cardiac Rhythm Management Market is highly fragmented and companies face intense competition. In 2012, the market lead...
Table of Contents                                                      List of Graphs & Tables1. Cardiac Rhythm Management...
4.2 Key Trends                                                 Boston Scientific Sales by Product Categories (2011)       ...
6.2.3 Business Strategies-Growth through Market Expansion-Growth through Acquisition Policy6.3 St. Jude Medical6.3.1 Busin...
Contact Us:                                View Report DetailsThese are abridged and sanitized sample pages from the compr...
Upcoming SlideShare
Loading in …5
×

Cardiac Rhythm Management (CRM) Market : 2012 Edition-Koncept Analytics

1,014 views

Published on

Cardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used for the treatment of arrhythmias and heart failure. Factors like market demand, innovative products, government regulations and reimbursement policies influence the CRM market. The market is facing slowdown in sales but with technological advancements, such as introduction of MRI pacemakers, subcutaneous ICDs, and home automated external defibrillators (AEDs), it is expected to bounce back.

The CRM market is mainly bifurcated into two segments viz. Implantable Cardioverter Defibrillators (ICD) market and Implantable Pacemakers market. For the past several years, pacemakers and ICDs have become a common therapy given to patients suffering from cardiac rhythm abnormalities. ICD is the larger segment of the CRM market in comparison with pacemakers. Sales of both the segments are likely to increase, resulting in the improvement of the overall cardiac rhythm management market. The competition in the global CRM market is intense with few large players viz. Medtronic, Boston Scientific and St. Jude Medical.

The key trends observed within the industry including the shifting focus towards primary prevention. On the development front, there has been a launch of new pacemakers as well as significant technological advancements in ICDs. However, the industry remains threatened by certain challenges. The major factors which will contribute in the growth of the industry include growing ageing population since with age people get more heart diseases, rising obese population, increasing cases of hypertension as high blood pressure is a major risk for heart attack and rising healthcare expenditure.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,014
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cardiac Rhythm Management (CRM) Market : 2012 Edition-Koncept Analytics

  1. 1. View Report Details Cardiac Rhythm Management Market--------------------------------------------------------- 2012
  2. 2. View Report DetailsExecutive SummaryCardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used forthe treatment of arrhythmias and heart failure. Factors like market demand, innovative products, government regulations andreimbursement policies influence the CRM market. The market is facing slowdown in sales but with the technological advancements suchas introduction of MRI pacemakers, subcutaneous ICDs, and home automated external defibrillators (AEDs), the market is expected tobounce back.CRM market is mainly bifurcated into two segments viz. Implantable Cardioverter Defibrillators (ICD) market and Implantable Pacemakersmarket. For the past several years, pacemakers and ICDs have become a common therapy given to patients who are suffering fromcardiac rhythm abnormalities. ICD segment of the CRM market is the larger segment in comparison with pacemaker. The sales of both thesegments are likely to increase resulting in improvement in the overall Cardiac Rhythm Management market.The present report offers a comprehensive analysis of the worldwide cardiac rhythm management market. The competition in the globalCRM market is intense with few large players viz. Medtronic, Boston Scientific and St. Jude Medical. The competitive landscape the globaland regional CRM markets, along with the company profiles of the leading players are discussed in detail.The key trends observed within the industry include shifted focus towards primary prevention. On the development front, there has beenlaunch of new pacemakers and technological advancements in ICDs. But there are certain challenges which the industry is facing as ofnow. The major factors which will contribute in the growth of the industry include growing ageing population since with age people getmore heart diseases, rising obese population, increasing cases of hypertension since high blood pressure is a major risk for heart attackand rising healthcare expenditure.By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of theindustry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Baseto determine the future direction of the industry. Before deploying the regression model, the relationship between several independent orpredictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
  3. 3. Cardiac rhythm management (CRM) is a field of treatment in cardiology, which primarily manages cardiac rhythm disorders.. Worldwide CRM Market Sales (Q111-Q412E) As of the first quarter of 2012, the sales of CRM market increased from US$..... million in the fourth quarter of 2011 to US$....... million, witnessing a growth of ……%. In the fourth quarter of 2012, the sales might increase by ……% reaching to US$...... million in comparison with last quarter of 2012. US$ Million The sales of CRM in the US decreased from US$..... million in the first quarter of 2012 to US$......million in the second quarter of 2012, reporting a decline of ……%. The sales of CRM market outside the US declined from US$...... million in first quarter of 2012 to US$...... million in second quarter of 2012, reporting a decline of …..%. •Industry Developments and trends: Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E -Shift in Focus towards Primary Prevention - Launch of New Pacemakers Worldwide CRM Market by Region (Q111-Q412E) - Technological Advancements in ICDs. Market Growth Drivers -Rising Ageing Population -Rising Obese Population -Increasing Case of Hypertension -Rising Healthcare Expenditure US$ Billion -Rise in consumption of alcohol and tobacco Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E The US Outside the US
  4. 4. CRM market is bifurcated into two segments viz. Implantable Cardiac Defibrillators (ICD) and Pacemaker Market.. Global CRM Market by Segments (2012E) In 2012, the ICD market is expected to account for ……% of the total CRM market, followed by pacemakers which are expected to account for ……% share of the total CRM market.  The sales of ICD market witnessed an increase of …..% by rising from US$..... million in the fourth quarter of 2011 to US$...... million in the first quarter of 2012. However, sales declined till third quarter to US$.... million in comparison with the previous quarters. But, this decline might get rebound in the last quarter of 2012 showing growth of ……%.  The sales for pacing systems registered an increase from US$...... million in the fourth quarter of 2011 to US$...... million in first quarter of 2012, reporting an improvement of ……%. In 2012, sales of pacing systems segment increase by ……% in the fourth quarter of 2012 after declining in second and third quarters of 2012. ICD Pacemaker Worldwide Pacing System Market Sales (Q111-Q412E) Worldwide ICD Market Sales (Q111-Q412E) US$ Million US$ Million Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E
  5. 5. The Cardiac Rhythm Management Market is highly fragmented and companies face intense competition. In 2012, the market leader in terms of revenue is expected to be Medtronic. Global CRM Market Forecast (2011-2015F) US$ Billion 2011 2012F 2013F 2014F 2015F On the competition front, Medtronic is expected to be the leading company in the market for cardiac rhythm management market world over, with approximately ……% of the market share for the year 2012, followed by St. Jude Medical and Boston Scientific with ……% and ….. % respectively.  The global CRM market is projected to record a value of US$..….. billion by the end of fiscal 2012 as compared to US$...... billion in 2011. The same is forecasted to reach US$...... billion by 2015, growing at a CAGR of approximately ……% during 2011 to 2015. Key Issues faced by the respective industry include: Inappropriate use and malfunctioning of CRM devices. Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa
  6. 6. Table of Contents List of Graphs & Tables1. Cardiac Rhythm Management: An Overview List of Charts1.1 ICD1.1.1 Types OF ICDs CRM Market Segment Basic Pacemaker Functional Diagram1.2 Pacing Systems Worldwide CRM Market Sales and Growth (Q111-Q412E)1.2.1 Types of Pacemakers Worldwide CRM Market by Region (Q111-Q412E) Global CRM Market by Segment (2012E)2. Cardiac Rhythm Management Market Worldwide ICD Market Sales and Growth (Q111-Q412E) The US ICD Market Sales and Growth (Q111-Q412E)2.1 Global Market Size Outside the US ICD Market Sales and Growth (Q111-Q412E) Worldwide Pacing System Market Sales and Growth Rate (Q111-2.2 CRM Market by Region Q412E) The US Pacing System Market Sales and Growth Rate (Q111-Q412E)3. CRM Market by Segments Outside the US Pacing System Market Sales and Growth Rate (Q111- Q412E)3.1 Implantable Cardiac Defibrillators (ICD) Market Worldwide Elderly Population (above 60 years of age) (2007-2012E)-Worldwide Market Growth in Worldwide Obese Population (2004-2012F)-US Market BP Pattern across various Stages of Hypertension-Outside US Market Hypertension Prevalence in the US (2010-2015E) Hypertension Prevalence in the Developed Europe (2010-2015E)3.2 Pacing Systems Market Healthcare Expenditure Worldwide (2005-2012E)-Worldwide Market Global CRM Share by Major Companies (2012E)-US Market Global ICD Market Share (2012E)-Outside US Market Global Pacemaker Market Share (2012E) CRM Market Share in the US (2012E) ICD Market Share in the US (2012E)4. Market Dynamics Pacemaker Market Share in the US (2012E) CRM Market Share outside the US (2012E)4.1 Growth Drivers ICD Market Share outside the US (2012E) Pacemaker Market Share outside the US (2012E)4.1.1 Rising Ageing Population Medtronic Sales by Product Categories (2012)4.1.2 Rising Obese Population Medtronic Sales by Region (2012)4.1.3 Increasing Cases of Hypertension Medtronic’s Total Sales and Net Income (2008-2012)4.1.4 Rising Healthcare Expenditure4.1.5 Rise in Consumption of Alcohol and Tobacco
  7. 7. 4.2 Key Trends Boston Scientific Sales by Product Categories (2011) Boston Scientific Sales by Region (2011)4.2.1 Shifted Focus towards Primary Prevention Boston Scientifics’ Total Sales and Net Income (2007-2011) St. Jude Medical Sales by Product Categories (2011)4.3 Challenges St. Jude Medical Sales by Region (2011)4.4 Industry Developments St. Jude Medical’s Total Sales and Net Income (2007-2011) Global CRM Market Forecast (2011-2015F)4.4.1 Launch of New Pacemakers4.4.2 Technological Advancements in ICDs List of Tables5. Competition-Global CRM Market Share Dependent & Independent Variables (2007-2011)-Global ICD Market Share Correlation Matrix-Global Pacemaker Market Share Model Summary – Coefficient of Determination Regression Coefficients Output5.1 The US-CRM Market Share-ICD Market Share-Pacemaker Market Share5.2 Outside the US (International)-CRM Market Share-ICD Market Share-Pacemaker Market Share6. Company Profiles6.1 Medtronic6.1.1 Business Overview6.1.2 Financial Highlights6.1.3 Business Strategies-Expansion through Strategic Acquisitions-Product Innovation6.2 Boston Scientific6.2.1 Business Overview6.2.2 Financial Highlights
  8. 8. 6.2.3 Business Strategies-Growth through Market Expansion-Growth through Acquisition Policy6.3 St. Jude Medical6.3.1 Business Overview6.3.2 Financial Highlights6.3.3 Business Strategies-Focus on New Product Launches-Growth through Strategic Acquisitions7. Market Outlook7.1 Market Forecast7.2 Forecast Methodology7.2.1 Dependent and Independent Variables7.2.2 Correlation Analysis7.2.3 Regression Analysis
  9. 9. Contact Us: View Report DetailsThese are abridged and sanitized sample pages from the comprehensive report on the “Cardiac Rhythm Management Market”.To know more about this report or for any customized research requirement, please contact the following: Koncept Analytics CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 Vikas Gupta T. +91-120-4130959 BD Manager C: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com

×